>9SFX_1|Chain A|Secukinumab Fv light-chain|Homo sapiens (9606)
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIKWSHPQFEK
>9SFX_5|Chain E[auth L]|Light-chain of anti-IL-17A antibody XAB5 (crystallization aid)|Homo sapiens (9606)
AIQLTQSPSSLSASVGDRVTITCRPSQGINWELAWYQQKPGKAPKLLIYDASSLENGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIKWSHPQFEK
>9SFX_4|Chain D[auth H]|Heavy-chain of anti-IL-17A antibody XAB5 Fv (crystallization aid)|Homo sapiens (9606)
EVQLVESGGDLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDRGSLYYWGQGTLVTVSSHHHHHH
>9SFX_3|Chain C|Interleukin-17A|Homo sapiens (9606)
GPIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
>9SFX_2|Chain B|Secukinumab Fv heavy-chain|Homo sapiens (9606)
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSSHHHHHH